Michał Hajt

Michał Hajt

Auto-generated profile, based on publicly available information

Michał Hajt

University Clinical Center of the Medical University of Warsaw, Poland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MHMichał Hajt
Michał Hajt
WMWeronika Martynowska
Weronika Martynowska
DMDastin Misiaszek
Dastin Misiaszek
AWAnna Wolszczak
Anna Wolszczak
Jakub MotorJakub Motor
Jakub Motor
PCPiotr Ciecierski
Piotr Ciecierski
Myocardial infarction (MI) among athletes is an uncommon but clinically significant event that has attracted growing attention because of its potential to cause sudden cardiac death (SCD) and long-term morbidity in an otherwise healthy population. This review synthesizes current literature on the epidemiology, pathophysiology, diagnostic evaluation, and preventive strategies for MI in athletes across age groups. In athletes younger than approximately 35 years, MI is rare and is more often attributable to non-atherosclerotic mechanisms—congenital coronary artery anomalies, spontaneous coronary artery dissection, coronary artery spasm, myocardial bridging, an oxygen supply–demand mismatch related to hypertrophic cardiomyopathy, or performance-enhancing substance use—than to classic atherosclerotic coronary artery disease. In masters athletes, generally older than 35 years, atherosclerotic plaque rupture or erosion, frequently triggered by the acute hemodynamic stress of intense exertion, becomes the predominant mechanism. Preparticipation cardiovascular screening, incorporating structured history-taking, physical examination, and standardized electrocardiographic interpretation criteria, together with the widespread availability of automated external defibrillators and bystander cardiopulmonary resuscitation training, constitutes the principal preventive strategy, although its optimal design and cost-effectiveness remain debated. Following an acute event, individualized, shared-decision-making approaches to return-to-play balance the cardiovascular and psychological benefits of continued exercise against residual arrhythmic and ischemic risk. Continued research into advanced imaging biomarkers, genetic testing, and risk-stratification tools is needed to refine clinical care for this distinctive population.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
Jakub MotorJakub Motor
Jakub Motor
MHMichał Hajt
Michał Hajt
DMDastin Misiaszek
Dastin Misiaszek
AWAnna Wolszczak
Anna Wolszczak
AGAlicja Graczyk
Alicja Graczyk
ZPZofia Parol
Zofia Parol
Autophagy is a key lysosome-dependent degradation pathway essential for maintaining cellular homeostasis, particularly in the highly secretory pancreas. This review summarizes recent advances in autophagy, selective autophagy, and vesicle trafficking in pancreatic physiology and disease. We focus on the dual role of autophagy, which can support cellular protection and organelle quality control, but also contribute to pathology when dysregulated. We highlight emerging molecular mechanisms linking autophagy with vesicle trafficking systems, including membrane remodeling, organelle contact sites, and key regulators such as VMP1 and Beclin-1. In addition, we discuss the role of autophagy in pancreatic inflammation and cancer, emphasizing its context-dependent function. Finally, we outline recent translational approaches targeting autophagy-related pathways, including pharmacological and genetic strategies, with potential diagnostic and therapeutic relevance in pancreatic diseases.

16 May 2026 in Quality in Sport
Verified
Journal Article
Open access
AGAlicja Graczyk
Alicja Graczyk
MHMichał Hajt
Michał Hajt
NGNatalia Grabowska
Natalia Grabowska
DMDastin Misiaszek
Dastin Misiaszek
AWAnna Wolszczak
Anna Wolszczak
PCPiotr Ciecierski
Piotr Ciecierski
Background: : Lipohipertrophy (LH) is a common complication of diabetes, regardless of its type, in which the tissue exposed to insuline lead to hypertrophy of adipocytes and fibrosis. Despite it looks like only a visual problem, it has many negative consequences, that pose a threat to patients' health, lives, and quality of life. Aim: In this article we would like to present the multiple dimensions affected by this complication, as well as the potential benefits associated with the treatment of LH. Methods: A narrative review was conducted using the medical databases PubMed, Google Scholar, and ScienceDirect, with a focus on the impact of insulin-induced LH on the health and daily functioning of patients with diabetes. Results: The following aspects were analyzed: the impact of LH on glycemic control, risks associated with glycemic variability, long-term complications, quality of life, effects on the management of comorbidities, mental health, and treatment-related costs. Each of these domains was found to be significantly impaired or complicated by the presence of LH. Furthermore, improvements in patient health outcomes were observed in cases where regression of LH lesions was achieved. Conclusion: The entirety of the reviewed literature indicates that LH constitutes a substantial clinical challenge. Early detection, prevention, and effective management are essential for improving disease control and enhancing the quality of life for patients with diabetes.

27 July 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NGNatalia Grabowska
Natalia Grabowska
AGAlicja Graczyk
Alicja Graczyk
MHMichał Hajt
Michał Hajt
DMDastin Misiaszek
Dastin Misiaszek
AWAnna Wolszczak
Anna Wolszczak
PTPaulina Turzyńska
Paulina Turzyńska
Crohn’s disease (CD) is a chronic, relapsing-remitting inflammatory disorder of the gastrointestinal tract in which impaired nutritional status and nutritional deficiencies are common. This issue is of major clinical relevance, as deficiencies in both macro- and micronutrients not only reflect disease activity but may also influence disease course, treatment efficacy, and patients’ quality of life. The pathogenesis of nutritional deficiencies in Crohn’s disease is multifactorial and includes malabsorption, reduced dietary intake, increased metabolic demand, nutrient loss, and the effects of pharmacotherapy. The most frequently observed deficiencies involve protein and energy, iron, vitamin B12, vitamin D, folate, and selected minerals such as zinc and magnesium. Their clinical consequences include anemia, impaired bone mineralization, immune dysfunction, delayed tissue repair, and overall deterioration in health status. The problem is particularly important in the pediatric population, in whom deficiencies may result in impaired growth and development. The aim of this review was to present the mechanisms leading to nutritional deficiencies in Crohn’s disease, discuss their clinical significance, and summarize current diagnostic and therapeutic strategies. The available evidence indicates that systematic nutritional assessment and appropriately selected nutritional interventions should constitute an integral part of comprehensive patient care.

2 July 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
AWAnna Wolszczak
Anna Wolszczak
WMWeronika Martynowska
Weronika Martynowska
MHMichał Hajt
Michał Hajt
DMDastin Misiaszek
Dastin Misiaszek
AGAlicja Graczyk
Alicja Graczyk
PTPaulina Patrycja Turzyńska
Paulina Patrycja Turzyńska
Introduction and purpose. Sarcopenic obesity (SO) is defined by the coexistence of excess adiposity and reduced muscle mass and function and is associated with disability, frailty, cardiometabolic disease, and increased mortality. This review aims to summarize current evidence on the definition and diagnosis of SO, assess the effects of incretin-based therapies on body composition, with a focus on practical strategies to reduce the risk of clinically relevant muscle loss during obesity treatment. Material and methods. This manuscript was prepared as a structured narrative review based on publications identified in PubMed/MEDLINE, Google Scholar, and the Cochrane Library. Results. Current evidence suggests that semaglutide and tirzepatide produce significant and sustained reductions in body weight and fat mass, including visceral adipose tissue, while also being associated with a decrease in absolute lean body mass. These changes should not be interpreted automatically as clinically relevant skeletal muscle loss. However, older adults, frail individuals, and patients with low muscle reserve are more susceptible, especially without adequate protein intake, resistance exercise, and regular monitoring. Conclusions. Incretin-based therapies represent a major advance in obesity treatment; however, in patients at risk of SO, they should be used within a multimodal strategy aimed at preserving muscle mass and function.

22 September 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PCPiotr Ciecierski
Piotr Ciecierski
WMWeronika Martynowska
Weronika Martynowska
AGAlicja Graczyk
Alicja Graczyk
JJJan Jakubczyk
Jan Jakubczyk
AWAnna Wolszczak
Anna Wolszczak
NMNatalia Malinowska
Natalia Malinowska
Physical activity (PA) is one of the fundamental elements of secondary prevention after acute coronary syndrome (ACS) and myocardial infarction (MI), as well as a key component of cardiac rehabilitation (CR). Available evidence indicates that higher levels of PA are associated with lower mortality, reduced risk of recurrent cardiovascular events, better physical capacity, improved quality of life, and more favorable control of cardiovascular risk factors. Despite these documented benefits, participation in CR and long-term maintenance of the recommended level of PA remain insufficient. Aim of the studyThe aim of this study was to present the role of PA in secondary prevention after MI, with particular emphasis on its impact on prognosis, physical capacity, quality of life, cardiovascular risk factors, and the importance of CR. Material and methodsA narrative literature review was conducted, including observational studies, randomized clinical trials, meta-analyses, and review articles concerning PA, CR, and secondary prevention after ACS and MI. ConclusionsPA and exercise-based CR are fundamental elements of post-MI care. Their benefits include improved prognosis, physical performance, quality of life, and modification of major cardiovascular risk factors. Improving access to CR, patient education, and long-term maintenance of PA should remain one of the main goals of secondary prevention.